CIFoundry
Back to Catalog
Cardiology
FDA 510(k) cleared (Jul 2023; expanded multi-device clearance Jan 2026); PVAD IQ cleared Feb 2026; CE, UKCA

UltraSight AI Cardiac Ultrasound Guidance

Save to shortlist
UltraSight2023

Last reviewed Nov 10, 2026 against the sources listed on this page · How we review

At a glance

UltraSight is AI guidance software that gives real-time probe-positioning feedback so clinicians without sonography training can capture diagnostic-quality views of the heart.

FDA:
510(k) K251416 +1 more
Epic:
Not on record
Named users:
Not on record
Published study:
Not on record

Description

UltraSight is AI guidance software that gives real-time probe-positioning feedback so clinicians without sonography training can capture diagnostic-quality views of the heart. Its Echo Stewardship Platform runs on existing handheld, laptop and cart ultrasound systems, and a separate tool (PVAD IQ) helps ICU teams check the position of Impella-type heart pumps on ultrasound.

EchocardiographyImage acquisition guidancePoint-of-care ultrasound

Quick answers

Answered only from the sourced records on this page. Questions we can't answer from the record are left out. How we review

Is UltraSight AI Cardiac Ultrasound Guidance FDA cleared?
The public FDA database has 2 records that our team matched to UltraSight AI Cardiac Ultrasound Guidance. The most recent is 510(k) K251416 (UltraSight Guidance), decided Dec 2025. Check that the cleared use matches how you plan to use it.FDA record K251416

Security & contracting

The maker has not reported these details yet. Ask the vendor directly during evaluation.

Workflow stage
Not reported
Integrations
Not reported
Data inputs
Not reported
Deployment
Not reported
Signs a BAA
Not reported
SOC 2 report
Not reported
HITRUST
Not reported
Evidence type
Not assessed

Readiness details are self-reported by the maker and are not checked by Clinical Intelligence Foundry. Evidence type describes the kind of study or document the listing links to; it is not a rating or endorsement. Confirm compliance documents with the vendor before purchase.

Who's using this

Organizations named in public announcements or by the developer. Inclusion is not an endorsement.

No public deployments found yet. Using this tool? The maker can claim the listing to add customers.

Get weekly updates for Cardiology

Up to 5 new items a week: new tools, FDA decisions and studies. Newest first, never ranked. Confirm by email, unsubscribe any time.

Sources

This listing links to primary sources. Follow the links below to check details directly with the developer, regulator or publication.

Website

FDA database records

  • K251416 · 510(k) · Dec 2025
    UltraSight Guidance
  • K223347 · 510(k) · Jul 2023
    UltraSight AI Guidance

Matched by our team from the public FDA database; checked Nov 10, 2026.

History (3)Show

Dated events on this listing's public record, newest first.

  1. Nov 10, 2026

    Added to CIFoundry

  2. Dec 17, 2025

    FDA 510(k) K251416 decision datesource

  3. Jul 24, 2023

    FDA 510(k) K223347 decision datesource

Developer

UltraSight

Evaluating this tool?

Get a printable packet for your committee: what the public record shows, the gaps to raise with the vendor, and the questions for this kind of tool.

Prepare evaluation packet

Checklist for your role: Admin · Physician · IT · Compliance

Compare similar tools →

Own this tool?

Claim this listing to update its details and connect with your audience.